VAMS® is the technology behind our user-friendly Mitra® devices, which are designed for remote specimen collection. VAMS retains the benefits of dried blood spot collection (DBS) cards while solving for their limitations. Overcome the hematocrit issue with Mitra and VAMS for easy and precise specimen collection, with reliable results.
Download these case studies for details on how to achieve the following benefits vs DBS cards:
|
|
When DBS cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation.
Yet, adoption was hindered by regulatory concerns over the "Hematocrit (HCT) Effect" and automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.
The Mitra® Microsampler is a remote specimen collection device that retains the advantages of DBS cards while overcoming their limitations.
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.